Table 4.
Patient Characteristics | Hazard Ratio | 95.0% CI for Exp (B)
|
P | |
---|---|---|---|---|
Lower | Upper | |||
| ||||
Age ≥45 years* | 12.2 | 4.3 | 34.8 | < 0.01 |
| ||||
Male | 0.8 | 0.4 | 1.6 | 0.48 |
| ||||
Race/ethnicity | ||||
Black (reference) | 0.59 | |||
White | 1.5 | 0.2 | 11.5 | 0.68 |
Other | 2.2 | 0.3 | 18.3 | 0.46 |
| ||||
Tumor size | ||||
≤1 cm (reference) | ||||
>1–2 cm | 0.8 | 0.4 | 1.7 | 0.61 |
| ||||
Regional lymph node metastasis* | 5.4 | 2.5 | 11.8 | <0.01 |
| ||||
Distant metastasis* | 6.4 | 2.8 | 14.4 | <0.01 |
| ||||
Extrathyroidal extension* | 2.8 | 1.3 | 5.9 | <0.01 |
| ||||
Subtotal or total thyroidectomy (reference) | 0.21 | |||
Lobectomy | 2.4 | 0.9 | 6.7 | 0.09 |
Less than lobectomy* | 13.7 | 1.7 | 110.6 | 0.01 |
| ||||
Radiotherapy | ||||
None (reference) | < 0.01 | |||
Radioisotopes | 1.1 | 0.5 | 2.4 | 0.88 |
XRT* | 8.9 | 3.1 | 25.1 | < 0.01 |
Combined XRT and radioisotopes* | 8.1 | 2.1 | 31.4 | < 0.01 |
Other | 2.9 | 0.3 | 24.6 | 0.34 |
Significant independent prognostic indicators